These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15275774)

  • 1. Antinociceptive mechanism of L-DOPA.
    Shimizu T; Iwata S; Morioka H; Masuyama T; Fukuda T; Nomoto M
    Pain; 2004 Jul; 110(1-2):246-9. PubMed ID: 15275774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed L-DOPA-induced hyperalgesia.
    Shimizu T; Iwata S; Miyata A; Fukuda T; Nomoto M
    Pharmacol Biochem Behav; 2006 Nov; 85(3):643-7. PubMed ID: 17141847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses.
    Paalzow GH
    J Pharmacol Exp Ther; 1992 Nov; 263(2):470-9. PubMed ID: 1432683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
    Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys.
    Doan VD; Grondin R; Hadj Tahar A; Grégoire L; Bédard PJ
    Clin Neuropharmacol; 1999; 22(5):281-7. PubMed ID: 10516879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
    Zarrindast MR; Asgari-Afshar A; Sahebgharani M
    Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments.
    Komatsu T; Sasaki M; Sanai K; Kuwahata H; Sakurada C; Tsuzuki M; Iwata Y; Sakurada S; Sakurada T
    Peptides; 2009 Sep; 30(9):1689-96. PubMed ID: 19520130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
    Taylor JL; Bishop C; Walker PD
    Pharmacol Biochem Behav; 2005 Aug; 81(4):887-93. PubMed ID: 16023708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine-induced painful neuropathy in mice.
    Kamei J; Tamura N; Saitoh A
    Pain; 2005 Sep; 117(1-2):112-20. PubMed ID: 16098672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
    Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of intrathecally administered hemokinin-1-induced nociceptive behaviors in mice.
    Watanabe C; Mizoguchi H; Yonezawa A; Sakurada S
    Peptides; 2010 Aug; 31(8):1613-6. PubMed ID: 20451571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
    Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
    Matsushita N; Misu Y; Goshima Y
    Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
    Buck K; Ferger B
    Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mexiletine on vincristine-induced painful neuropathy in mice.
    Kamei J; Nozaki C; Saitoh A
    Eur J Pharmacol; 2006 Apr; 536(1-2):123-7. PubMed ID: 16556439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted rats.
    Visanji NP; Millan MJ; Brotchie JM
    Exp Neurol; 2006 Nov; 202(1):85-92. PubMed ID: 16814282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of nitric oxide on morphine-induced amnesia and interactions with dopaminergic receptor agents.
    Rezayof A; Amini R; Rassouli Y; Zarrindast MR
    Physiol Behav; 2006 Jun; 88(1-2):124-31. PubMed ID: 16631214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.